CUHK Centre for Bioethics
Chinese University of Hong Kong
CUHK's centre convenes bioethics scholarship around biomedical innovation, clinical decisions and culturally grounded approaches to global health ethics.
Research focus
Its interdisciplinary forums bring law, health policy, philosophy and clinical practice into conversation on AI, prenatal testing, reproductive autonomy, assisted dying and the place of non-Western moral traditions in care.
Researchers
-
Roger Yat-Nork Chung
Co-director; associate professor
Uses bioethics and social epidemiology to investigate health inequality, migration and end-of-life care.
Selected reading
-
Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing (opens in a new tab)
Nikolajs Zeps et al., 2021
Sets out ethical and regulatory questions raised by translating somatic epigenetic editing into clinical use, especially uncertainty around safety and the boundary between research and treatment.
Co-authored by Alexandre Erler of the CUHK Centre for Bioethics and Department of Philosophy.
-
The moral burden of 'slow code' resuscitation in Hong Kong and its implications for advance medical decision legislation (opens in a new tab)
Roger Y N Chung and W Zhong, 2025
Uses the ethically fraught practice of symbolic resuscitation to examine how advance medical decisions can reduce uncertainty for patients, families and clinical teams in Hong Kong.
Co-written by Roger Chung of the CUHK Centre for Bioethics.
Sources
- “CUHK Centre for Bioethics.” bioethics.med.cuhk.edu.hk (opens in a new tab)
- “CUHK Centre for Bioethics celebrates 10th anniversary by gathering global experts to address bioethical challenges in science and medicine.” med.cuhk.edu.hk (opens in a new tab)
- “Professor CHUNG Yat-nork Roger.” bioethics.med.cuhk.edu.hk (opens in a new tab)
- “Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.” PubMed (opens in a new tab)
- “The moral burden of 'slow code' resuscitation in Hong Kong and its implications for advance medical decision legislation.” PubMed (opens in a new tab)
The researchers above are named as part of this program’s public profile, not as directory people with a documented affiliation.
Official source reviewed .